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Cathepsin B-like and cell death in the unicellular
human pathogen Leishmania
AK El-Fadili1, H Zangger1, C Desponds1, IJ Gonzalez1, H Zalila1, C Schaff1, A Ives1, S Masina1, JC Mottram2 and N Fasel*,1
In several studies reporting cell death (CD) in lower eukaryotes and in the human protozoan parasite Leishmania, proteolytic
activity was revealed using pan-caspase substrates or inhibitors such as carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-
fluoromethylketone (Z-VAD-FMK). However, most of the lower eukaryotes do not encode caspase(s) but MCA, which differs from
caspase(s) in its substrate specificity and cannot be accountable for the recognition of Z-VAD-FMK. In the present study, we were
interested in identifying which enzyme was capturing the Z-VAD substrate. We show that heat shock (HS) induces Leishmania
CD and leads to the intracellular binding of Z-VAD-FMK. We excluded binding and inhibition of Z-VAD-FMK to Leishmania major
metacaspase (LmjMCA), and identified cysteine proteinase C (LmjCPC), a cathepsin B-like (CPC) enzyme, as the Z-VAD-FMK
binding enzyme. We confirmed the specific interaction of Z-VAD-FMK with CPC by showing that Z-VAD binding is absent in a
Leishmania mexicana strain in which the cpc gene was deleted. We also show that parasites exposed to various stress
conditions release CPC into a soluble fraction. Finally, we confirmed the role of CPC in Leishmania CD by showing that, when
exposed to the oxidizing agent hydrogen peroxide (H2O2), cpc knockout parasites survived better than wild-type parasites (WT).
In conclusion, this study identified CPC as the substrate of Z-VAD-FMK in Leishmania and as a potential additional executioner
protease in the CD cascade of Leishmania and possibly in other lower eukaryotes.
Cell Death and Disease (2010) 1, e71; doi:10.1038/cddis.2010.51; published online 2 September 2010
Subject Category: Immunity
In unicellular organisms, several studies reported phenotypic
markers of cell death (CD), when cells were exposed to
environmental stress such as temperature shock, oxidizing
agents, microbial peptides or drugs.1,2 Although these reports
provided some indication of the existence of a CD pathway in
unicellular organisms with similarities to programmed cell
death (PCD), experimental evidence of genetically encoded
program(s) is still lacking.
Leishmania is an interesting unicellular model organism to
study the CD machinery. In the insect vector, Leishmania
differentiates from proliferating non-infectious procyclic to
non-dividing infectious stationary metacyclic promastigotes.
When the parasites are transmitted to its mammalian host,
they are phagocytosed by macrophages and differentiate into
amastigotes that survive in a phagolysosome. Thus, in both
stages, Leishmania parasites must control their growth,
maintain their virulence possibly by selecting the fittest
parasites and resist the oxidative attack of the innate immune
system of the host.3–5 Dead or dying promastigotes were
shown to enable the intracellular survival of the viable
parasites,6,7 to influence parasite virulence and modulate
the host immune response.
In higher eukaryotes, caspases have a role in the initiation
and the execution of the different CD pathways. Plants and
lower eukaryotes (e.g., yeast and protozoan parasites such as
Leishmania) do not encode caspase(s) but metacaspases
(MCA), which could be precursors of caspases.8 These
cysteine proteases harbor the predicted secondary structure
with the catalytic dyad histidine/cysteine9,10, and were found
to be auto-processed and to recognize mainly substrates with
arginine residues in the P1 position.11–13 Thus, MCA have
substrate specificities that differ from metazoan caspase
usual substrates and are likely not to be accountable for
recognition of caspase substrates or inhibitors as reported in
several studies.14–17
The presence of other proteases acting in the Leishmania
CD pathway could explain the recognition of substrates such
as carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoro-
methylketone (Z-VAD-FMK), a cell permeate pan-caspase
inhibitor. This caspase inhibitor binding was used as a
phenotypic marker of CD in yeast cells or protozoan parasites
undergoing CD13,18–20 and was also shown to block CD in
lower eukaryotes such as Dictyostelium.21 This lead to a
confusing situation as these organisms do not code for
caspase.
In this study, we report that Z-VAD-FMK does not inhibit
LmjMCA activity but binds to cathepsin B-like (CPC) enzyme,
providing an explanation for the detection of caspase
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substrates binding in organisms lacking caspase genes.
Furthermore, we provide evidence that CPC is present in
a soluble formwhenCD is induced by various inducers. Based
on these data, we propose that CPC has a role in the CD
machinery of Leishmania parasites and likely in other lower
eukaryotes.
Results
Heat shock (HS) treatment of Leishmania parasites leads
to intracellular binding and accumulation of the caspase
inhibitor fluorescein isothiocyanate-valyl-alanyl-aspartyl-
[O-methyl]-fluoromethylketone (FITC-VAD-FMK). Several
studies have reported that dying unicellular organisms
bind fluorescent-conjugated caspase inhibitors such as
Z-VAD-FMK. To investigate this binding, Leishmania para-
sites were exposed to a HS treatment at 551C for 10min
followed by incubation overtime with FITC-VAD-FMK (from
30min to 2 h). FITC-VAD-FMK accumulation was monitored
by fluorometry (Figure 1a). No significant binding was
observed in untreated parasites (white columns), whereas
HS-treated parasites exhibited a rapid entry and accumulation
of FITC-VAD-FMK. In addition, Z-VAD-FMK intracellular
accumulation is time dependent, reaching a maximum
after 30min and then decreases overtime. These results
were further supported by fluorescence microscopy where
FITC-VAD-FMK binding was detected only when parasites
were exposed to HS (Figure 1b). To quantify the percentage of
Figure 1 Evaluation of FITC-VAD-FMK binding in Leishmania promastigotes. (a) FITC-VAD-FMK accumulation in L. major wild-type cells was measured after their
exposure (HS treated) or not (non-treated) to HS by fluorometry. Fluorescence of intracellular FITC-VAD-FMK was monitored overtime every 30min for 2 hours. Average of
triplicate measurements is shown. (b) FITC-VAD-FMK accumulation was visualized by fluorescence microscopy. After HS exposure (þHS) or not (HS), parasites are
incubated for 30min with the FITC-VAD-FMK (þ FITC-VAD (300) and analyzed by microscopy. (c) Quantification of FITC-VAD-FMK-positive parasites upon HS treatment by
flow cytometry. Leishmania WT exposed to HS (þHS; right panel) compared with untreated parasites (HS; left panel) were stained with FITC-VAD-FMK and
propidium iodide (PI)
Cathepsin B-like CPC and cell death in Leishmania
AK El-Fadil et al
2
Cell Death and Disease
parasites binding the FITC-VAD-FMK, we performed a
FACS analysis. Over 92% of the parasites were binding the
substrate upon HS treatment (Figure 1c). Similar results were
obtained when hydrogen peroxide (H2O2) or nitric oxide (NO)
were used as CD inducers, albeit binding of Z-VAD-FMK was
delayed and maximal only after 120min (data not shown).
Leishmania MCA peptidase activity is not inhibited by
Z-VAD-FMK. Having shown that stressed parasites bind
fluorescent-conjugated caspase inhibitors, we wondered
whether this inhibitor had any effect on the MCA activity.
We tested this possible inhibition of LmjMCA activity by
Z-VAD-FMK towards the optimized tetrapeptide substrate
VRPR22 in a functional heterologous complementation of a
Saccharomyces cerevisiae MCA null mutant (Dyca1)
using the L. major MCA catalytic domain (cd-LmjMCAwt).
The specificity of LmjMCA for the fluorogenic substrate
Ac-Val-Arg-Pro-Arg-7-amino-4-methylcoumarin (Ac-VRPR-AMC)
peptide was measured in total protein extracts of Dyca1 cells
expressing cd-LmjMCA (Figure 2). As expected, significant
activity for cd-LmjMCA with the Ac-VRPR-AMC substrate
was obtained when compared with the vector control but
activity was completely abrogated when the catalytic dyad
was mutated at amino acid histidine 147 or cysteine 202. To
be sure that Ac-VRPR-AMC is a sensitive enough substrate,
we also compared the levels of activity of cd-LmjMCA with
this substrate and other peptidyl substrates previously
evaluated.12 cd-LmjMCA was found to be twice more active
with Ac-VRPR-AMC than with Z-GGR-AMC and almost 10
times more active than with Boc-GRR-AMC (data not
shown). These results further confirm that LmjMCA has
mainly an arginine-directed cysteine peptidase as reported
previously,12 closely related to the described plant AtMC9
MCA, and that Ac-VRPR-AMC could be used in our assay to
exclude Z-VAD-FMK as an inhibitor of LmjMCA activity.
Total protein extracts of Dyca1 yeast cells expressing
cd-LmjMCA were tested for their enzymatic activity with
Ac-VRPR-AMC substrate in the presence of high concentra-
tions of the broad caspase inhibitor Z-VAD-FMK, the cysteine
protease inhibitor E64, and leupeptin (Figure 2). Z-VAD-FMK
and E64 had no significant inhibition of cd-LmjMCA activity
when tested with Ac-VRPR-AMC (Figure 2). Interestingly,
leupeptin, a serine protease inhibitor, which also inhibits some
calpains and cathepsins, completely abrogated cd-LmjMCA
activity. These results demonstrate that the VRPR-AMC is
a substrate for LmjMCA as for the Arabidopsis thaliana
MCAAtMC9,22 that cleavage of the substrate is dependent on
the catalytic activity of LmjMCA and that this activity is not
inhibited by Z-VAD-FMK or E64, known inhibitors of caspase
and cathepsin L, respectively. The recognition of substrates
such as Z-VAD in dying cells might be explained by the
binding to other proteases acting in the Leishmania CD
pathway.
Biotin-VAD-FMK binds to specific polypeptides in
HS-treated Leishmania parasites but does not bind
to LmjMCA. To biochemically characterize Z-VAD-FMK-
binding polypeptide(s), we replaced FITC-VAD-FMK with a
biotin-VAD-FMK (b-VAD-FMK; Figure 3). Untreated para-
sites incubated in the absence or in the presence of b-VAD-
FMK were used as controls to detect any binding unrelated to
the action of stress inducers or to detect non-specific binding
of the avidin-peroxidase (Figure 3a, lanes 1 and 2). When
parasites were exposed to HS and subsequently incubated
with b-VAD-FMK, several polypeptides of apparent mole-
cular masses of 34 and 47 kDa could be detected by the
avidin-peroxidase conjugate (Figure 3a). No detection of
these polypeptides was noted when biotin-VAD-FMK was
omitted from the reaction. Considering that these poly-
peptides migrated with molecular masses in the range of
precursor and processed forms of LmjMCA, the same
samples were further analyzed for the expression and the
processing of LmjMCA using the previously characterized
anti-MCA antibody (Figure 3b).12 Following HS treatment,
LmjMCA precursor is efficiently cleaved generating two main
bands with apparent molecular masses of 29 and 45 kDa.
The band corresponding to the processed catalytic domain of
LmjMCA migrating with a molecular mass of 29 kDa differed
to that of b-VAD-FMK-detected bands, which migrated with
an apparent molecular mass of 34 kDa. Similarly, the biotin-
binding 47 kDa band migrated slower than the 45 kDa band
detected by the anti-MCA antibody (Figure 3b). Thus, the b-
VAD-FMK-binding polypeptides differ from Leishmania MCA
polypeptides, confirming the results obtained with the
LmjMCA activity inhibition experiment (Figure 2).
CPC is the binding partner of the Z-VAD-FMK substrate
in HS-, H2O2- or miltefosine-treated Leishmania
parasites. To identify the enzyme responsible for b-VAD-
FMK binding, we performed an affinity pull-down of the
‘enzyme–biotin-VAD-FMK’ complex using an avidin column
followed by protein separation on a 1D gel. The gel was
stained by Coomassie blue, and the 34 and the 47 kDa
stained bands present in the HS-treated samples were
isolated and further analyzed using peptide fingerprinting and
Figure 2 Effect of Z-VAD-FMK, E64 and leupeptin on cd-LmjMCA enzymatic
activity. Protein extracts from Dyca1 yeast cells transfected with the pESC-His
vector alone (vector control) and expressing the catalytic domain of LmjMCA
(cd-LmjMCA) wild type (wt), and its respective H147A and C202A catalytic site
mutants were evaluated for their specific activity with the Ac-VRPR-AMC substrate
in the absence or the presence of 100mM of Z-VAD-FMK, E64 and leupeptin.
The AMC release was measured every 15min for 2 h to determine the activity as the
slope of the resulting linear regression. Relative activity was calculated as the fold
increase relative to the activity of the vector control (with and without protease
inhibitors). Means and S.D. are indicated. *Po0.05
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mass spectrometry. Database search for homology at the
primary amino acid sequence of the 47 kDa band did not
allow us to detect any tryptic peptides corresponding to
LmjMCA or to any enzyme which could bind VAD-FMK.
In the 34 kDa eluted band, however, we could identify
tryptic peptides corresponding to CPC, a CPC enzyme, as
a possible b-VAD-FMK-binding polypeptide. CPC has a
predicted molecular mass of 37.7 kDa in the precursor form
and of 34 kDa in the active processed form.23 In the
Leishmania genome, CPC is encoded by a single gene
LmjF29.0820. To further confirm CPC as the b-VAD-FMK-
binding partner, we studied b-VAD-FMK binding in
L. mexicana cpc knockout parasites as well as in cpc
complemented lines.24 After HS treatment and incubation in
the presence or in the absence b-VAD-FMK substrate,
samples were separated by SDS-PAGE and binding of
b-VAD-FMK was revealed by avidin-peroxidase. Binding of
b-VAD-FMK was detected only in parasites expressing
CPC, for example, in L. mexicana wild type (WT) and in
the cpc knockout complemented cell line (cathepsin B-like
deficient parasites complemented with cpc episomal copy
(cpc KO/þ )), respectively (Figure 4a), as revealed by
the presence of 34 kDa band. No signal was detected in the
cpc knockout parasites (cathepsin B-like-deficient parasites
(cpc KO); Figure 4a). As expected, the signals corresponded
to the expected molecular mass of the CPC processed
form. The reason for the presence of a doublet at 34 kDa in
HS-treated cells is not known. In HS-treated L. mexicana, no
47 kDa species was detected by the avidin-peroxidase,
confirming that this biotin-binding polypeptide is likely to be
a non-specific binding of b-VAD-FMK when L. major
parasites are HS treated.
To confirm that Z-VAD-FMK binding is not restricted to
HS-treated parasites, we have analyzed the cpc null mutants
using chemical and therapeutic CD inducers. Treated
L. mexicana WT, cpc KO and cpc KO/þ parasites with
H2O2 were further incubated with b-VAD-FMK and its binding
to CPC was revealed by avidin-peroxidase (Figure 4b).
Similar to HS, H2O2 treatment leads to binding of Z-VAD-
FMK to CPC, as the 34 kDa polypeptide is detected only in
parasites expressing CPC (Figure 4b, lanes 2 and 6). No
signal was visible in cpc KO cells (Figure 4b, lane 4).
Second, the binding of Z-VAD-FMK to CPC was also
induced by the anti-Leishmania drug miltefosine, a drug
known to disrupt the lysosomal membrane (Figure 4c). When
parasites were treated overnight with 40 mM of miltefosine,
followed by b-VAD-FMK incubation, the release of the 34 kDa
was visible only in parasites expressing CPC (Figure 4c, lanes
2 and 6). Again, no specific signal was detected in the cpc KO
parasites (Figure 4b, lane 4). These results suggest that CPC
is present and released from the lysosomewhen parasites are
exposed to different CD inducers including HS, H2O2 or
miltefosine and that, at least in our experimental design, the
proteolytic activity of CPC, as detected by the binding of
b-VAD-FMK substrate, could be involved in the CD pathway
of Leishmania parasites.
Finally, to show that the release of CPC from the lysosome
occurred following exposure to different inducers, we used a
rat antiserum raised against a recombinant CPC, and
analyzed CPC expression and release in both treated and
untreated cells. Wild-type L. mexicana, cpc KO and a cpc
KO/þ were exposed to HS, H2O2 or miltefosine (Figures 4d,
e, and f). Expression and release of CPC was analyzed in a
NP-40 soluble fraction. In these experiments, we expected
to detect not only the processed CPC enzyme but also its
precursor form, if these different treatments provoked the
rupture of the fragile lysosomal membrane and consequent
release of enzymes into the cytoplasm of the dying parasite.
Upon treatment with HS, H2O2 or miltefosine, two poly-
peptides with molecular masses of 34 and 38 kDa were
specifically recognized by the anti-CPC antiserum in WT and
cpc KO/þ parasites, but not in cpc KO parasites (Figures 4d,
e, and f). These two polypeptides migrated at the expected
sizes for CPC precursor and processed forms, respectively.
These CPC precursor and processed forms were also
detected in untreated parasites albeit at a lower level.
Figure 3 VAD-FMK binds to specific polypeptides that are not related to Leishmania MCA. Western blot analysis of non-treated WT and HS-treated parasites after their
incubation (þ b-VAD) or not ( b-VAD) with biotin-VAD-FMK (b-VAD). Protein extracts were obtained after parasite lysis using NP-40 buffer and analyzed by immunoblot
with avidin-HRP (a) and anti-MCA (b). Black arrows indicate the two bands of 34 and 47 kDa, respectively, that were detected to bind the Z-VAD-FMK substrate (a, lane 4).
Black dashed arrow indicates full-length LmjMCA (b, lanes 1 and 2) and black arrows indicate lower molecular weight cleavage products of LmjMCA (b, lanes 3 and 4)
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The reason for such a presence in untreated parasites is likely
to be because of the rupture of some lysosomes during the
fractionation procedure thereby contaminating the NP-40
soluble fraction.
CPC participates to the Leishmania CD pathway. If CPC
is involved in Leishmania CD, it is expected that cpc
knockout parasites survive better to reactive oxygen
species (ROS) or to chemotherapeutics drugs. We,
therefore, performed viability tests of L. mexicana WT, cpc
KO parasites and cpc KO/þ parasites in the presence of
different concentrations of H2O2. Viability was measured in
stationary parasites using the MTS assay. Increasing the
concentration of H2O2 from 0.1 to 1mM induced the death of
over 40% of the parasites (Figure 5) suggesting that, at high
concentrations, CD is induced independently of the presence
or the absence of CPC. Interestingly, at 0.5mM of H2O2, cpc
KO parasites survive better than parasites expressing CPC
and show a higher survival rate (100%) as compared with
WT cells (70%) or cpc KO/þ cells (65%; Figure 5). This
result suggests that CPC activation increased the parasites’
sensitivity to death signals, as lack of CPC enhanced the
parasites’ survival to death stimuli.
To provide a more detailed analysis of the CD process,
we measured the exposure of phosphatidylserine at the
cytoplasmic membrane of L. mexicana WT, CPC KO and
CPC KO/þ lines with FITC-labeled Annexin V. Parasites with
a loss of integrity in their membrane (necrotic cells) were
detected with 7-AAD (Figure 6). When parasites were treated
with 1mM H2O2 for 1 h (Figure 6), we noticed that parasites
expressing CPC (e.g. WT and cpc KO/þ cells) exhibited a
high rate of necrotic (7-AADþ ) and late apoptotic (AnVþ /7-
ADDþ ) cells, whereas cpc-deficient cells (cpc KO) show a
low percentage of necrotic and late apoptotic cells, as shown
by calculating the ratios of percentage of AnVþ /7-AAD,
AnVþ /7-AADþ and AnV/7-AADþ cells to percentage of
AnV/7-AAD (Table 1). These results confirmed that CPC-
expressing Leishmania exhibit an enhanced sensitivity to
undergo CD. In our assay, this sensitivity is almost abrogated
when parasites are lacking CPC. In addition, we noticed
that the CD kinetics differ between parasites expressing CPC
and the null mutants. When parasites are exposed to H2O2
(Figure 6, Table 1), both WT and CPC KO/þ show low rate
of early apoptotic cells (AnVþ /7-AAD) compared with
CPC KO parasites (Figure 6, Table 1). Similar results
were obtained when cells were exposed to HS or miltefo-
sine (data not shown). In the light of these results, we can
conclude that CPC expression is directly linked to the parasite
sensitivity to CD inducers. Thus, parasites lacking CPC are
more resistant to the lethal effect of environmental and
chemical CD stimuli. Our results also suggest that CD in
Leishmania could implicate not only the release of LmjMCA12
Figure 4 Detection of Z-VAD-FMK binding in CPC-deficient mutants by western blot. (a–c) Parasites’ extracts were analyzed for Z-VAD-FMK binding using avidin-HRP.
All parasites were exposed (þ ) or not () to HS (a), H2O2 (b) or miltefosine (c), and incubated with biotin-VAD-FMK (þ b-VAD). Protein extracts were derived from WT,
cpc KO and cpc KO. (d–f), Total protein extracts from WT, cpc KO and cpc KO/þ cell lines exposed (þ ) or not () to HS (d), H2O2 (e) or miltefosine (f) and incubated with
biotin-VAD-FMK (þ b-VAD) were further analyzed for CPC expression using a CPC anti-serum. Black arrows indicate the two major forms of the CPC protein (34 and 38 kDa,
respectively)
Figure 5 CPC-deficient parasites are more resistant to H2O2-induced death.
WT, cpc KO and cpc KO/þ were measured for viability using the MTS assay.
Parasites were treated with increasing concentrations of H2O2 for 1 hour. Results
are a mean of triplicates and expressed as a relative percentage of viability.
Experiment was repeated at least three times independently
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but also the release of a soluble form of CPC enzyme. Thus,
previous studies showing Z-VAD-FMK binding may be
integrated into a model, taking into account a proteolytic
cascade, implicating CPC proteolytic activity.
Discussion
A CD program could control the density of Leishmania
population in the insect stage, be involved in the virulence of
the inoculum, in the innate immune response when parasites
are killed in the host phagolysosome by NO or H2O2, in the
control of the parasite density in the macrophage and in the
chemosensitivity of parasites to specific drugs.
In this study, we decided to solve the confusing issue of
detection of the pan-caspase Z-VAD-FMK substrate binding
to dying unicellular cells using Leishmania as amodel system.
After having excluded that b-VAD-FMK binds and inhibits
MCA, we demonstrated that b-VAD-FMK is binding to an
Figure 6 Phosphatidylserine exposure at the membrane of Leishmania cells treated with H2O2. WT (column a), cpc KO (column b) and cpc KO/þ (column c) that contain
an episomal copy of cpc were not treated () or treated (þ ) with 1M H2O2 for 1 h. Cells were stained with fluorescein isothiocyanate (FITC)-labeled Annexin V and 7-AAD to
distinguish between live (AnV/7AAD), apoptotic (AnVþ /7AAD, early apoptotic cells; AnVþ /7AADþ , late apoptotic cells) and necrotic cells (AnV/7AADþ ).
(d) Percentage of AnV/7AAD, AnVþ /7AAD, AnVþ /7AADþ and AnV/7AADþ in WT, cpc KO and cpc KO/þ when non-treated () or treated (þ ) with 1mM
H2O2 for 1 h after staining with fluorescein isothiocyanate (FITC)-labeled Annexin V and 7-AAD (a–c)
Table 1 Kinetics of the parasites’ death under H2O2 treatment
AnV (+) 7-AAD () AnV (+) 7-AAD (+) AnV () 7-AAD (+)
Wild-type () H2O2 0.033 0.007 0.004
Wild-type (+) H2O2 0.14 0.42 0.79
CPC KO () H2O2 0.29 0.07 0.02
CPC KO (+) H2O2 0.29 0.28 0.18
CPC KO/+ () H2O2 0.16 0.04 0.02
CPC KO/+ (+) H2O2 0.32 0.45 0.53
Wild-type parasites (WT), cathepsin B-deficient parasites (cpc KO) and cpc KO complemented strain (cpc KO/+) that contain an episomal copy of cpc were not
treated () or treated (+) with 1mMH2O2 for 1 h. Cells were stained with fluorescein isothiocyanate (FITC)-labeled Annexin V and 7-AAD to distinguish between live
(AnV/7AAD), apoptotic (AnV+/7AAD, early apoptotic cells; AnV+/7AAD+, late apoptotic/necrotic) and necrotic cells (AnV/7AAD+) as depicted in Figure 6.
Values correspond to ratios of percentage of AnV+/7-AAD, AnV+/7-AAD+ and AnV/7-AAD+ cells to percentage of AnV/7-AAD
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active CPC in stress situations only. These data provide
strong evidence that at least part of CD in Leishmania may
function via CPC and result in consequent release of
cathepsins into the cytoplasm.
Our results are consistent with our previous report showing
that, upon induction of CD by HS or NO, lysosomal cathepsins
L (i.e., CPA and CPB) were released into the cytoplasm.25
However, in the previous study, we did not provide any
evidence of the functional role of Leishmania CPA, CPB or
CPC. The data presented here suggest that, among CPs,
Leishmania CPC is involved in CD. These results do not
exclude, however, the participation of CPA and CPB in the
proteolytic degradation of the cellular components. As
revealed by the inhibition observed with the use of the CP
inhibitor E-64, these CPs could be responsible for the
activities toward caspase-like substrates such as the
DEVDase activity detected in axenic amastigote-like para-
sites, but not in the free-living promastigote.25 Our results on
the function of CPC in CD and the binding of b-VAD-FMK have
been obtained in promastigote parasites. In the light of these
results, it will be important to evaluate further CPs’ activities in
the different life stages of the parasite, using different
substrates and single null mutants (Dcpa, Dcpb and Dcpc)
to provide answers to the respective role of each CP in the
CD pathway.
Our results also explain the detection of b-VAD-FMK
binding observed in several dying unicellular organisms.
Biotin-VAD-FMK binding could not be explained by binding
to caspase(s), as caspase genes are absent in these
organisms. Thus, binding of Z-VAD-FMK to an active CPC
in dying cells could be a general process in the CD pathway in
unicellular organisms. In higher eukaryotes, cathepsin B was
shown to bind Z-VAD-FMK. Cathepsin B has been shown to
bind b-VAD-FMK in other organisms26,27 and to be involved in
PCD pathways in mammalian cells, arguing in favor of a
lysosomal membrane permeabilization implicated in CD.28,29
Interestingly, mammalian cathepsins were observed to
participate in the apoptotic cascade of hepatocytes, neuronal
cells and T lymphocytes.30–32 Furthermore, cathepsins were
shown to participate directly or indirectly inmitochondrial outer
membrane permeabilization (MOMP) with release of cyto-
chrome c and in the activation of caspases 9 and 3.33 In other
systems, the CP inhibitor E-64 was shown to block PCD in the
dinoflagellate Peridinium.34 This class of proteases could be,
in concert with LmjMCA, one of the main executioner
proteases in lower eukaryotes. It is not known yet whether
release of lysosomal enzymes is selective as observed in
mammalian cells.35,36
Our experimental data, using wild-type parasites (WT), cpc
KO, and complemented line, tend to demonstrate that when
CPC is present, the percentage of necrotic cells increase.
Thus far, we cannot conclude whether we are confronted to a
simple necrosis or a programmed necrosis such as necrop-
tosis.37 Whether dying unicellular organisms are simply using
existing enzymatic activities by default in stress situations
(circumstantial death) or whether the CD pathway is geneti-
cally encoded needs further studies. The presence of several
common mediators in metazoa and in unicellular organisms,
as proposed by a bioinformatics comparison,38 and the
detection of similar phenotypic markers in higher and lower
eukaryotes suggest that CD is controlled in unicellular
organisms. Although the role of cathepsins and other
mediators needs to be studied in other organisms, our data
support the hypothesis that PCD or PCD-like was present
early in evolution and that PCD in metazoa could have
evolved from a common pathway. In this context, one possible
common early pathway may have been based on the rupture
of the fragile lysosomal membrane by oxidative stress and
consequent release of lysosomal enzymes. In this hypothesis,
other lysosomal enzymes, and especially the abundant CPs,
would be released into the cytoplasm and could participate in
the degradation of cellular components. MOMP could be
induced by cathepsins, which would lead to the release of
cytochrome c and the formation of ROS. The latter would have
a permeabilization effect on lysosomal and mitochondrial
membranes.31 This lysosomal pathway is likely to be used for
different stress stimuli, by some antiparasitic drugs such as
miltefosine, a drug known to induce apoptotic CD via both the
intrinsic mitochondrial pathway and a lysosomal pathway in
mammalian cells.39
Materials and Methods
Chemicals. Reagents, unless otherwise stated, were purchased from Sigma–
Aldrich Inc. (St Louis, MO, USA).
Culture of Leishmania promastigotes. L. major MRHO/IR/75/ER
promastigotes, L. mexicana wild-type cells and L. mexicana deletion mutants
(cpc KO and cpc KO/þ )24 were grown until stationary phase at 261C in M199
medium (Invitrogen AG, Basel, Switzerland) supplemented with 10% heat-
inactivated FCS (Seromed GmbH, Wien, Switzerland), 40mM N-2-hydroxy-
ethylpiperazine-NO-2-ethanesulfonic acid (Hepes, pH 7.0), 100 U/ml penicillin and
100mg/ml streptomycin.
FITC-VAD-FMK accumulation assay. 1 108 stationary phase parasites
were exposed to a HS at 551C for 10min followed by 1 h incubation at 261C.
Treated parasites were centrifuged at 1400 g and washed with 1 PBS, then
further incubated with 10mM FITC-VAD-FMK (Promega Corp., Madison, WI, USA)
for different time points. The labeled parasites were centrifuged at 1400 g and
washed with 1 PBS. Parasites’ pellets were resuspended in 1 PBS and
dispensed in 96-well culture plate for fluorescence measurement. Fluorescence was
measured using the Muli-Detection Microplate Reader Synergy 2 (Biotek
instruments; Witec AG, Littau, Switzerland) at an excitation wavelength of 355 nm
and an emission wavelength of 460 nm. All incubation steps were at 261C.
Flow cytometric analysis, confocal and fluorescence
microscopy. Stress induced parasites were washed, resuspended in
AnnexinV (AnV)-binding buffer (HEPES 10mM, NaCl 150mM, CaCl2 2.5 mM) at
pH 7.2. Cells were incubated at room temperature (RT) for 15min with AnV-FITC
(BD Biosciences Pharmingen, Allschwill, Switzerland) at the concentration indicated
by the manufacturer. At the moment of acquisition, 0.4 mg/ml of propidium iodide
(BD Biosciences Pharmingen) was added to control and AnV-FITC-labeled
samples. Data were collected in a BD FACSCaliburH and analyzed by Cellquest
ProH (BD Biosciences, San Jose, CA, USA). A total of 10 000 gated events were
harvested from each sample. For confocal microscopy, HS-treated parasites were
incubated for 30min to 5 h in the presence or absence of 10 mM of FITC-VAD-FMK
(Promega Corp.) in M199-complemented medium. As a control, the same
procedure was followed using untreated parasites. Hence, labeled parasites were
washed with 1 PBS and adhered to poly-L-lysine-treated coverslips. Slides were
mounted with Vectashield mounting medium with DAPI (Vector Laboratories,
Burlingame, CA, USA). Mounted slides were visualized using a Zeiss LSM 510 UV
META Laser Scanning Confocal Microscope.
MCA enzymatic activity. Protein extracts from MCA null mutant (Dyca 1)
yeast cells transfected with the pESC-His vector alone (vector control) or expressing
either the catalytic domain of LmjMCA (cd-LmjMCA) wildtype (wt), or its respective
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H147A and C202A catalytic mutants were evaluated for their specific activity toward
the fluorogenic peptidyl substrate Ac-VRPR-AMC. Transfected yeast cells were
harvested following 24 h induction with 2% galactose. Total protein extracts were
prepared in a lysis buffer containing 50mM KH2PO4, (pH7.5), 500mM NaCl, 1 mM
EDTA, 5 mM DTT and 1% CHAPS. Enzymatic activity was then evaluated with
40mg of total protein diluted in 200ml of activity buffer (25mM HEPES, 150mM
NaCl, 10mM CaCl2, 10% glycerol, 0.1% CHAPS and 10mM DTT) and incubated
with 100mM of the Ac-VRPR-AMC.12 MCA activity toward Ac-VRPR-AMC was
tested in the presence of 100mM of Z-VAD-FMK, E64 or leupeptin. In all cases, the
release of AMC was measured at each 10min for 2 h by spectrofluorometry using
an excitation wavelength of 355 nm and an emission wavelength of 460 nm.
Enzymatic activity was determined as the slope of the resulting linear regression
and expressed as the fold increase relative to the activity of the vector control.
Biotin-VAD-FMK-binding assay. 1.5 108 stationary phase parasites
were treated with three different death inducers such us H2O2 (1mM for 1 h),
HS(10min at 551C, followed by 1 h incubation at 261C) or miltefosine (40 mM for
24 h). Treated parasites were centrifuged at 1400 g and washed with 1 PBS,
then further incubated with 100mM biotin-VAD-FMK (Promega Corp.) for 20min at
RT. The parasites were then centrifuged at 1400 g and washed with 1 PBS and
pellets were resuspended in cold NP-40 lysis buffer (0.14 M NaCl, 1.5 mM MgCl2,
10mM Tris-HCl, 0.5% Nonidet P40, 2 mM EDTA, 40 ng/ml leupeptin, 10 mg/ml
pepstatin, 0.8 mM o-phenanthroline and 160mM E64). Parasite lysates were
centrifuged at 13 200 g at 41C for 3 min. Protein concentration was quantified
using a BCA protein assay reagent (Pierce Biotechnology, Inc., Rockford, IL, USA)
with BSA as a standard. Cleared lysates and their respective pellets were stored at
701C for further analysis.
Purification of the enzyme–Biotin-VAD-FMK complex and MS
analysis. IR75 parasites were grown (3–4 107/ml), exposed to HS for 10min
at 551C and then left at RT for 1 h. After washing the parasites in 1 PBS, they
were resuspended in 200ml of 1 PBS and 100ml of biotinyl-VAD(Ome)-FMK
from Alexis for 20min at RT, washed once in 1 PBS, resuspended in 200ml of
NP-40 lysis buffer in the presence of protease inhibitors, left for 1 min on ice and
centrifuged at 13 200 g for 3 min. The supernatant was diluted 4 in 1 PBS,
and 60ml of streptavidin-agarose beads prewashed in 1 PBS was added,
incubated for 30min at RT on a wheel. The beads were recovered after
centrifugation, washed three times with one volume of 1 PBS. One volume of
1 PBS was added to the volume of the beads. The beads were incubated at 941C
for 5min in 1 Laemmli’s gel sample buffer and the total was loaded on a 10%
SDS-polyacrylamide gel. The gel was stained by Coomassie blue and stained
bands were cut and analyzed by mass spectrometry after trypsin digestion.40
Cell lysis and immunobloting. Stationary promastigotes were lysed in a
solution containing 0.14M NaCl, 1.5 mM MgCl2, 10mM Tris-HCl, 0.5% Nonidet
P40, 2mM EDTA, 40 ng/ml leupeptin, 10 mg/ml pepstatin, 0.8 mM o-phenanthroline
and 160mM E64. Protein concentration was quantified using a BCA protein assay
reagent (Pierce Biotechnology, Inc.) with BSA as a standard. Twelve percent
SDS-PAGEs were used to separate 10–20mg of total protein from parasite lysates.
Proteins were transferred to a nitrocellulose membrane by electroblotting and
probed with either avidin HRP antibody (BD Biosciences), rat polyclonal antibodies
raised against the L. major CPC or rabbit polyclonal antibodies produced against a
synthetic 76-mer amino acid peptide (ER53) from the caspase-like domain of
the Trypanosoma brucei TbMCA2/3 MCA.12 Filters were exposed to horse-
radish peroxidase-conjugated secondary antibodies (Promega Corp.) and
developed by enhanced chemiluminescent staining using ECL western blotting
system (Amersham Biosciences, Piscataway, NJ, USA). Low-range mole-
cular weight standards were used as reference proteins (Bio-Rad Laboratories,
Hercules, CA, USA).
Test for apoptotic markers. Annexin V staining was performed as
described previously12 with some modifications. Briefly, 1 107 stationary
promastigotes either exposed or not for 1 h to 1 mM of H2O2 were washed and
resuspended in Annexin V binding buffer (10mM HEPES (pH 7.4), 140mM NaCl,
2.5 mM CaCl2 and 1.2 M sorbitol). Parasites were incubated in the dark for 15min at
RT with 5ml Annexin V-FITC (Invitrogen AG). Before FACS analysis, 2.5ml of
7-AAD was added to the samples in a final volume of 250ml. In all, 50 000 events
were accumulated with a BD FACScan apparatus and data were analyzed using the
CellQuest (Becton–Dickinson Biosciences, San Jose, CA, USA) and Flowjo
(Tree Star Inc., Ashland, OR, USA) softwares.
MTS assay. The toxicity of H2O2 for the parasites was determined 1 h after
exposure to the oxidative stress agent using the MTS tetrazolium (Promega Corp.).
In all, 2 106 parasites were dispensed in 96-well culture plate and exposed or not
to 1 mM H2O2 for 1 h. H2O2 action was stopped by addition of 50 units of catalase to
the samples. Samples in the well plates were treated using 50 ml of MTS tetrazolium
and incubated for 2–3 h (261C) in a 5% CO2 incubator. Once coloring developed,
the absorbance of 200ml of each sample was analyzed at 490 nm using the
Muli-Detection Microplate Reader Synergy2 (Biotek instruments, Witec AG).
Statistical analysis. All the experiments were performed at least three times
independently, and means and S.D. were calculated. The Student’s t-test was used
in statistical analysis.
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